RESUMO
Lormetazepam (0.5, 1, 2, 4, 8 mg)--a new benzodiazepine--was tested versus Pentobarbital (100 mg) under double blind conditions on 240 preoperative inpatients for night-time sedative and side effects after acute oral intake. Results are based on p less than 0.05. Additionally p less than 0.125 in binomial-two-sample-tests was accepted. Lormetazepam shows dose dependent increase in hypnotic effects (e.g. reduction in sleep latency and number of awakenings, increase of total sleep duration), and side effects (e.g. dopiness, dizziness), but no relevant change in vital signs. About 0.5 mg of Lormetazepam are equivalent to 100 mg of Pentobarbital. 2 mg of Lormetazepam seem to be the optimum dose regarding the relation between hypnotic and side effects. In the view of anaesthesists Lormetazepam is preferable to Pentobarbital because of more favorable safety aspects.
Assuntos
Ansiolíticos/uso terapêutico , Lorazepam/uso terapêutico , Distúrbios do Início e da Manutenção do Sono/tratamento farmacológico , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pentobarbital/uso terapêutico , Cuidados Pré-Operatórios , Equivalência TerapêuticaRESUMO
One minor anomaly of the external ear is a "third crus", which is an addition to the normal upper and lower crura at the anterior end of the anthelix. Another minor deformity is an extension of the crus of the helix, wherein it runs as a crest across the concha. An operation to correct the latter deformity is described.
Assuntos
Orelha Externa/anormalidades , Orelha Externa/cirurgia , Humanos , Cirurgia PlásticaRESUMO
We present 6 cases of Mondor's disease which developed after plastic surgical operations on the breasts. All signs of the disease disappeared spontaneously after 3 or 4 months.